Jennifer L. Taubert, EVP, WWC. Innovative Medicine at JOHNSON & JOHNSON (JNJ), sold 112,942 shares at $177.81 ($20.1M) on 2025-09-04, disclosed to the SEC on 2025-09-05.
Open-market sale of $20.1M JNJ by EVP, WWC. Innovative Medicine. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $177.81 | 56,471 | $10.0M | 50.0% |
| 2 | $177.81 | 56,471 | $10.0M | 50.0% |
| Total | $177.81 avg | 112,942 | $20.1M | 100% |
| Filing → |
| JNJ | SELL | 2022-11-23 | $27.2M | — | Filing → |